Squamous cell carcinoma of the hypopharynx+1
RecruitingStudy on Advanced Laryngeal and Hypopharyngeal Cancer: Comparing Docetaxel, Cisplatin, and Pembrolizumab for Patients Eligible for Laryngectomy
Study on Advanced Laryngeal and Hypopharyngeal Cancer: Comparing Docetaxel, Cisplatin, and Pembrolizumab for Patients Eligible for Laryngectomy
- Disease:Squamous cell carcinoma of the hypopharynxLaryngeal cancer
- Substances:CisplatinDexamethasone+2
Germany- Participants:18–64 years · 65+ years
- Substances:Cisplatin
- Sponsor:Universitaet Leipzig










